Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN)
Recruiting
Observational Study
Cervix Cancer
Endometrial Cancer
Epithelial Ovarian Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 120 (estimated)
- Sponsor
- Region Västerbotten · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational study is to learn about the added diagnostic and prognostic value of advanced medical imaging procedures in cervical cancer, endometrial cancer and ovarian cancer. The main questions it aims to answer are:
* Does advanced medical imaging predict survival?
* Can advanced medical imaging improve radiotherapy target planning?
* Are advanced medical imaging results asso…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Previously untreated primary cervical, endometrial, or strongly suspected epithelial ovarian cancer.
* Known clinical FIGO stage.
* \>18 years old.
* No other known current or previous malignancy within the last 10 years.
Exclusion Criteria:
* Imaging findings suggestive of …
Contacts